Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 49,504 | 39,503 | 28,519 | 29,664 | 16,352 |
| Cost of Goods | 6,190 | 5,038 | 3,724 | 3,815 | 2,356 |
| Gross Profit | 43,314 | 34,465 | 24,795 | 25,849 | 13,996 |
| Operating Expenses | 58,775 | 94,427 | 104,382 | 86,081 | 85,148 |
| Operating Income | -15,271 | -59,924 | -78,863 | -59,417 | -70,796 |
| Interest Expense | 16,108 | 17,518 | 18,071 | 18,593 | 18,484 |
| Other Income | 1,406 | 1,632 | 2,618 | 3,559 | 3,703 |
| Pre-tax Income | -29,973 | -75,810 | -94,316 | -74,451 | -85,577 |
| Net Income Continuous | -29,973 | -75,810 | -94,316 | -74,451 | -85,577 |
| Net Income | $-29,973 | $-75,810 | $-94,316 | $-74,451 | $-85,577 |
| EPS Basic Total Ops | -0.41 | -1.05 | -1.31 | -0.99 | -1.32 |
| EPS Basic Continuous Ops | -0.41 | -1.05 | -1.31 | -0.99 | -1.32 |
| EPS Diluted Total Ops | -0.41 | -1.05 | -1.31 | -0.99 | -1.32 |
| EPS Diluted Continuous Ops | -0.41 | -1.05 | -1.31 | -0.99 | -1.32 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.90 | -1.15 | -0.88 | -1.32 |
| EBITDA(a) | $-14,340 | $-59,018 | $-77,990 | $-58,595 | $-70,016 |